Microbix Advances Test-Ingredient Manufacturing Capabilities
MISSISSAUGA, Ontario, June 04, 2024 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX:MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has successfully adapted and extended the use of its bioreactor capabilities for production of another clinically and commercially-important test-ingredient (a native “Antigen”). This achievement will enhance production capacity for the referenced native Antigen, improve Microbix’s ability to schedule and allocate its manufacturing resources, and provide economic benefits.